Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy

Autor: Christopher A. Alabi, Nir Ben-Tal, Alexander L. Greninger, Ksenia Rybkina, A. des Georges, Matteo Porotto, V. Más, A. Moscona, Tara C. Marcink, Francesca T. Bovier, Elon Yariv
Přispěvatelé: Marcink, T. C., Yariv, E., Rybkina, K., Mas, V., Bovier, F. T., des Georges, A., Greninger, A. L., Alabi, C. A., Porotto, M., Ben-Tal, N., Moscona, A., National Institute of Allergy and Infectious Diseases (United States)
Rok vydání: 2020
Předmět:
Antiviral agent
viruses
Cell Culture Techniques
Sialic acid binding
Viral protein structure
Microbiology
Antiviral Agents
Virus
Cell Line
Cell membrane
Small Molecule Libraries
03 medical and health sciences
Viral entry
Virology
Viral receptor
Drug Discovery
medicine
Humans
Viral fusion protein
Cryo-electron tomography
030304 developmental biology
Host cell membrane
0303 health sciences
HN Protein
Paramyxoviridae Infections
030306 microbiology
Chemistry
Epithelial Cells
Virus Internalization
Therapeutics and Prevention
Fusion protein
Small molecule
cryo-electron tomography
QR1-502
3. Good health
Cell biology
High-Throughput Screening Assays
Parainfluenza Virus 3
Human

Molecular Docking Simulation
viral fusion protein
Antiviral agents
medicine.anatomical_structure
Viral Receptor
viral protein structure
Viral Fusion Proteins
viral receptor
Protein Binding
Research Article
Zdroj: mBio
mBio, Vol 11, Iss 1, p e03203-19 (2020)
Repisalud
Instituto de Salud Carlos III (ISCIII)
mBio, Vol 11, Iss 1 (2020)
ISSN: 2150-7511
Popis: Paramyxoviruses, including human parainfluenza virus type 3, are internalized into host cells by fusion between viral and target cell membranes. The receptor binding protein, hemagglutinin-neuraminidase (HN), upon binding to its cell receptor, triggers conformational changes in the fusion protein (F). This action of HN activates F to reach its fusion-competent state. Using small molecules that interact with HN, we can induce the premature activation of F and inactivate the virus. To obtain highly active pretriggering compounds, we carried out a virtual modeling screen for molecules that interact with a sialic acid binding site on HN that we propose to be the site involved in activating F. We use cryo-electron tomography of authentic intact viral particles for the first time to directly assess the mechanism of action of this treatment on the conformation of the viral F protein and present the first direct observation of the induced conformational rearrangement in the viral F protein.
The receptor binding protein of parainfluenza virus, hemagglutinin-neuraminidase (HN), is responsible for actively triggering the viral fusion protein (F) to undergo a conformational change leading to insertion into the target cell and fusion of the virus with the target cell membrane. For proper viral entry to occur, this process must occur when HN is engaged with host cell receptors at the cell surface. It is possible to interfere with this process through premature activation of the F protein, distant from the target cell receptor. Conformational changes in the F protein and adoption of the postfusion form of the protein prior to receptor engagement of HN at the host cell membrane inactivate the virus. We previously identified small molecules that interact with HN and induce it to activate F in an untimely fashion, validating a new antiviral strategy. To obtain highly active pretriggering candidate molecules we carried out a virtual modeling screen for molecules that interact with sialic acid binding site II on HN, which we propose to be the site responsible for activating F. To directly assess the mechanism of action of one such highly effective new premature activating compound, PAC-3066, we use cryo-electron tomography on authentic intact viral particles for the first time to examine the effects of PAC-3066 treatment on the conformation of the viral F protein. We present the first direct observation of the conformational rearrangement induced in the viral F protein.
Databáze: OpenAIRE